Showing 19,641 - 19,660 results of 125,061 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (mean decrease)) ))', query time: 1.55s Refine Results
  1. 19641

    Image5.PDF by Brittney N. Keel (4886881)

    Published 2018
    “…Mapping sequence reads onto a reference genome is a fundamental step in the analysis of NGS data. …”
  2. 19642

    Table5.DOCX by Brittney N. Keel (4886881)

    Published 2018
    “…Mapping sequence reads onto a reference genome is a fundamental step in the analysis of NGS data. …”
  3. 19643
  4. 19644
  5. 19645

    Proteomic Analysis of the Murine Liver in Response to a Combined Exposure to Psychological Stress and 7,12-Dimethylbenz(a)anthracene by Melanie S. Flint (2263015)

    Published 2010
    “…Changes in protein abundances derived from spectral counting indicates that stress alone results in increases in the abundance of proteins responsive to oxidative stress, along with Phase I and II metabolizing enzymes, such as CYP2J5 and UDP glucoronytransferases. The proteomic results further indicate that exposure to DMBA induces increases in the abundance of CYP1A2 and serine protease inhibitors and decreases the abundance of CYP4 V3. …”
  6. 19646

    Proteomic Analysis of the Murine Liver in Response to a Combined Exposure to Psychological Stress and 7,12-Dimethylbenz(a)anthracene by Melanie S. Flint (2263015)

    Published 2010
    “…Changes in protein abundances derived from spectral counting indicates that stress alone results in increases in the abundance of proteins responsive to oxidative stress, along with Phase I and II metabolizing enzymes, such as CYP2J5 and UDP glucoronytransferases. The proteomic results further indicate that exposure to DMBA induces increases in the abundance of CYP1A2 and serine protease inhibitors and decreases the abundance of CYP4 V3. …”
  7. 19647

    Proteomic Analysis of the Murine Liver in Response to a Combined Exposure to Psychological Stress and 7,12-Dimethylbenz(a)anthracene by Melanie S. Flint (2263015)

    Published 2010
    “…Changes in protein abundances derived from spectral counting indicates that stress alone results in increases in the abundance of proteins responsive to oxidative stress, along with Phase I and II metabolizing enzymes, such as CYP2J5 and UDP glucoronytransferases. The proteomic results further indicate that exposure to DMBA induces increases in the abundance of CYP1A2 and serine protease inhibitors and decreases the abundance of CYP4 V3. …”
  8. 19648

    A daily living function assessment. by Yoriko Aoki (17847445)

    Published 2024
    “…The secondary endpoint decision-making participation was assessed using the Control Preference Scale (CPS) decision-making roles and a 10-point Visual Analog Scale for participation rate. …”
  9. 19649
  10. 19650
  11. 19651

    Image_5.TIF by Yumeng Shi (1351218)

    Published 2018
    “…</p>Results<p>Knockdown SOX5 decreased lamellipodium formation, migration, and invasion of RA-FLS. …”
  12. 19652
  13. 19653
  14. 19654

    Image_5.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…Selective blockade of CCR1 (Met-RANTES therapy) in infected Ccr5<sup>−/−</sup> mice supported a protective role for CCR1 in CCC. …”
  15. 19655
  16. 19656
  17. 19657
  18. 19658
  19. 19659

    Lung and serum IL-7 and B precursors IL-7R expression during allergic inflammation. by Konstantinos Samitas (2938953)

    Published 2016
    “…<p>IL-7 levels in the a) lung and b) serum are not affected by allergen exposure. c) Expression of IL-7R was decreased upon allergic exposure. d) No differences were found in the intensity of the expression of the IL-7R in total B cells (B220+SSC<sup>low</sup>) and pre-B cells (B220<sup>+</sup>CD43<sup>-</sup>BP<sup>-</sup>1<sup>+</sup>), while in pre/early pro-B cells (B220<sup>+</sup>CD43<sup>+</sup>BP-1<sup>-</sup>) it was decreased during allergic inflammation. …”
  20. 19660

    Baseline characteristics. by Si-Jing Chen (15350263)

    Published 2025
    “…In addition, the CBT-I group reported a greater decrease in depressive (adjusted difference −1.0 [−1.6 to −0.5]; Cohen’s <i>d</i> = 0.53; <i>p</i> < 0.001) and insomnia symptoms (−2.0 [−2.7 to −1.3], <i>d</i> = 0.78; <i>p</i> < 0.001) than the controls at post-intervention and throughout 6-month follow-up. …”